Christopher Peetz is Chief Executive Officer and Director of Mirum Pharmaceuticals, Inc. (MIRM). The company reported total compensation of $10,441,224 for fiscal year 2025.
| Salary | $755,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $3,683,904 |
| Option awards | $4,931,320 |
| Non-equity incentive plan | $1,057,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $10,441,224 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Mirum Pharmaceuticals, Inc. filed April 23, 2026, accession 0001759425-26-000027.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and Director | $755,000 | $0 | $3,683,904 | $4,931,320 | $1,057,000 | $0 | $14,000 | $10,441,224 |
| FY2024 | Chief Executive Officer | $730,000 | — | $2,218,206 | $2,844,495 | $792,050 | — | $13,800 | $6,598,551 |
| FY2023 | Chief Executive Officer | $660,000 | $0 | $1,761,000 | $3,383,920 | $633,600 | $0 | $13,200 | $6,451,720 |
Totals as disclosed in each year's own compensation disclosure for Mirum Pharmaceuticals, Inc..
| Peer-group chief executive median | $9,841,656 |
|---|---|
| Difference from that median | $599,569 |
| Percentile within the disclosed peer group | 50th |
| Peers with a disclosed figure | 12 |
Medians and percentiles are computed across the peer group Mirum Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Peetz this page | Chief Executive Officer and Director | $10,441,224 |
| Peter Radovich | President and Chief Operating Officer | $3,964,270 |
| Eric Bjerkholt | Chief Financial Officer | $3,246,216 |
| Joanne Quan | Chief Medical Officer | $3,246,216 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Mirum Pharmaceuticals, Inc. compensation brief.
Christopher Peetz's compensation sits inside Mirum Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.